C07K 14/685
Alpha-melanotropin
C07K14/685 (Alpha-melanotropin) appears on 110 US grants and 112 published applications in this corpus.
Search patents in C07K- Granted patents
- 110
- Published applications
- 112
- Assignees
- 72
- Inventors
- 201
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 5 |
| 2003 | 3 | 3 |
| 2004 | 2 | 4 |
| 2005 | 4 | 7 |
| 2006 | 1 | 3 |
| 2007 | 5 | 4 |
| 2008 | 2 | 6 |
| 2009 | 1 | 7 |
| 2010 | 1 | 4 |
| 2011 | 2 | 5 |
| 2012 | 1 | 5 |
| 2013 | 8 | 5 |
| 2014 | 6 | 5 |
| 2015 | 3 | 3 |
| 2016 | 6 | 7 |
| 2017 | 6 | 7 |
| 2018 | 2 | 10 |
| 2019 | 6 | 6 |
| 2020 | 4 | 4 |
| 2021 | 5 | 3 |
| 2022 | 3 | 5 |
| 2023 | 2 | 0 |
| 2024 | 2 | 0 |
| 2025 | 3 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Conjugation of MCR1 ligand with cytotoxic drugs for treating skin cancer14 Oct 2025US 12,440,570 B2Arizona Board of Regents on Behalf of the University of Arizona
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages20 May 2025US 12,303,555 B2Nanyang Technological University
- Method of treating melanocortin-4 receptor pathway-associated disorders1 Apr 2025US 12,263,202 B2Rhythm Pharmaceuticals, Inc.
- Peptide compositions3 Sep 2024US 12,077,612 B2Rhythm Pharmaceuticals, Inc.
- Cyclic peptide analogs of melanocortin and amanitin and methods of making such30 Jan 2024US 11,884,714 B2Provincial Health Services Authority
- Engineered nucleic acids and methods of use thereof6 Aug 2026US 2026/0224664 A1Moderna TX, Inc.
- Compositions for the treatment of disease4 Jun 2026US 2026/0151434 A1SightStream Biotherapeutics, Inc.
- Method of treating melanocortin-4 receptor pathway-associated disorders19 Jun 2025US 2025/0195606 A1Rhythm Pharmaceuticals, Inc.
- Peptide compositions12 Jun 2025US 2025/0188124 A1Rhythm Pharmaceuticals, Inc.
- Cyclic peptide analogs of melanocortin and amanitin and methods of making such22 Sep 2022US 2022/0298219 A1Provincial Health Services Authority
Most cited
By later US patents
- Engineered nucleic acids and methods of use thereof372US 8,822,663 B2Moderna Therapeutics, Inc. · 2014
- DNA sequencing by mass spectrometry via exonuclease degradation235US 6,074,823 ASequenom, Inc. · 2000
- Peptides having potent antagonist and agonist bioactivities at melanocortin receptors102US 5,731,408 AArizona Board of Regents on Behalf of the University of Arizona · 1998
- Hybrid protein101US 4,675,382 APresident and Fellows of Harvard College · 1987
- Melanocortin receptor ligands91US 6,613,874 B1The Procter & Gamble Company · 2003